Yonga G O, Oyuga H W, Njeru E K
Department of Clinical Pharmacology, College of Health Sciences, University of Nairobi, Kenya.
East Afr Med J. 1993 Jul;70(7):402-4.
Beta-blockers that are non-selective, beta-1-selective or possess intrinsic sympathomimetic activity (ISA) are thought to differ in their effects on serum potassium, glucose and lactate during exercise. In a randomized, double-blind, cross-over, placebo-controlled study, 21 healthy male volunteers took placebo, propranolol, pindolol and metoprolol on separate occasions. They were subsequently exercised using the same exercise protocol on each visit and serum levels of potassium, glucose and lactate determined before and after exercise. Only propranolol (non-selective beta-blocker with no ISA) was associated with significantly higher increases in serum potassium and glucose than placebo (p = 0.000). Increases in serum lactate levels with exercise were not significantly different between propranolol, pindolol (non selective blockers with ISA), metoprolol (beta-1-selective blocker with ISA) and placebo. Interference with metabolic responses to exercise associated with beta-blockade is modified by beta-1-selectivity and ISA amongst indigenous Kenyans.
非选择性、β1选择性或具有内在拟交感活性(ISA)的β受体阻滞剂在运动期间对血清钾、葡萄糖和乳酸的影响被认为有所不同。在一项随机、双盲、交叉、安慰剂对照研究中,21名健康男性志愿者在不同时间服用安慰剂、普萘洛尔、吲哚洛尔和美托洛尔。随后,他们在每次就诊时采用相同的运动方案进行运动,并在运动前后测定血清钾、葡萄糖和乳酸水平。只有普萘洛尔(无ISA的非选择性β受体阻滞剂)与血清钾和葡萄糖的显著升高相关,高于安慰剂(p = 0.000)。普萘洛尔、吲哚洛尔(有ISA的非选择性阻滞剂)、美托洛尔(有ISA的β1选择性阻滞剂)和安慰剂之间,运动引起的血清乳酸水平升高没有显著差异。在肯尼亚原住民中,β1选择性和ISA会改变与β受体阻滞剂相关的对运动代谢反应的干扰。